1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Doximity, Inc.

Doximity, Inc.

DOCS
Doximity, Inc.US flagNew York Stock Exchange
21.66
USD
+0.14
- -
4.05BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.57
0.77
1.16
2.1
2.17
2.5
3.05
3.45
3.45
Basic EPS, GAAP
0.05
0.2
0.28
0.95
0.58
0.78
1.19
1.05
1.05
Free Cash Flow per Basic Share
0.1
0.15
0.44
0.74
0.9
0.94
1.43
1.7
1.7
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.09
0.2
1.17
1.13
0.42
1
-0.27
-0.27
Tangible Book Value per Share
- -
- -
0.21
5.21
4.48
4.24
5.31
4.44
4.44
Basic Weighted Avg Shares
151
151
178
163
193
190
187
187
187
Sales/Revenue/Turnover
86
116
207
344
419
475
570
645
645
Operating Margin (%)
8.08
19.04
25.76
33.05
29.86
36.14
40.34
33.33
33.33
Depreciation Expense
1
1
4
5
10
10
11
14
14
Net Income, GAAP
8
30
50
155
113
148
223
196
196
Effective Tax Rate (%)
1.24
- -
13.08
- -
15.27
20.31
15.32
21.58
21.58
Profit Margin (%)
9.14
25.55
24.27
45.05
26.92
31.04
39.13
30.4
30.4
Working Capital
- -
67
107
793
836
766
932
789
789
LT Debt
- -
- -
- -
- -
14
12
10
8
8
Total Equity
- -
1
67
879
966
901
1,083
951
951
Return on Invested Capital (%)
- -
- -
132.61
- -
11.38
14.33
19.27
16.36
16.36
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
135.95
55.12
98.97
167.02
- -
724.22

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
188
185
183
Market Capitalization
13,738
8,319
4,357

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,092
993
944
Cash, Cash Equivalents & STI
878
735
749
Accounts Receivable, Net
129
157
145
Inventories
- -
- -
- -
Total Current Liabilities
140
150
155
Payables & Accruals
23
67
32
ST Debt
2
2
2
Deferred Revenue
100
66
106

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
245.52%
-12.17%
Free Cash Flow
- -
33.83%
19.03%
Net Income, GAAP
- -
50.21%
-12.16%
Sales/Revenue/Turnover
- -
26.9%
13.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
108
114
135
118
475
2025
127
137
169
138
570
2026
146
169
185
145
645

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
0.16
0.26
0.22
0.78
2025
0.22
0.24
0.4
0.33
1.19
2026
0.28
0.33
0.33
0.1
1.05

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Jeffrey A. Tangney
Full Time Employees
880
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500, 3rd Street San Francisco CA United States of America 94107
IPO Date
Jun 24, 2021
CIK
0001516513
Website
doximity.com
Similar Companies
Aspyra Inc. (APYI)
Imaging Biometrics Ltd. (IBAI.L)
Nurosene Health Inc. (MNNDF)
Oakridge International Limited (U9O0.F)
Vanfund Urban Investment and Development Co., Ltd. (000638.SZ)
Renalytix Plc (RENX.L)
Business
I will refine the search specifically for latest major company changes for Doximity, Inc. to find accurate and recent updates.

Company News

APIChatGPT

  • zacks.com

    Doximity (DOCS) Declines More Than Market: Some Information for Investors

  • zacks.com

    Reasons to Retain Doximity Stock in Your Portfolio for Now

  • businesswire.com

    Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

  • businesswire.com

    Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety

  • zacks.com

    Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors

  • prnewswire.com

    Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • seekingalpha.com

    Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories

  • benzinga.com

    Doximity's AI Expansion Raises Execution Risks: Analyst

  • zacks.com

    Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • zacks.com

    Doximity (DOCS) Advances While Market Declines: Some Information for Investors

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • zacks.com

    Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?

  • prnewswire.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Doximity, Inc. – DOCS

  • gurufocus.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

  • prnewswire.com

    DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm